Australia - English - Department of Health (Therapeutic Goods Administration)

organon pharma pty ltd - betamethasone dipropionate, quantity: 0.64 mg/g (equivalent: betamethasone, qty 0.5 mg/g) - ointment - excipient ingredients: white soft paraffin; propylene glycol; propylene glycol monostearate; white beeswax - for the relief of the inflammatory and pruritic manifestations of resistant or severe corticosteroid responsive dermatoses. these include atopic eczema, nummular eczema, contact dermatitis, neurodermatitis, anogenital and senile pruritus, lichen planus and psoriasis. diprosone ov ointment is also indicated for the maintenance of remission in chronic psoriasis.

Australia - English - Department of Health (Therapeutic Goods Administration)

organon pharma pty ltd - betamethasone dipropionate, quantity: 0.64 mg/g (equivalent: betamethasone, qty 0.5 mg/g) - ointment - excipient ingredients: white soft paraffin; liquid paraffin - topical treatment of corticosteroid-responsive dermatoses. these include atopic eczema, infantile eczema, nummular eczema, contact dermatitis, neurodermatitis, anogenital and senile pruritus, lechen planus, intertrigo and psoriasis. indications as at 26 august 1992: eleuphrat is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. these include atopic eczema, infantile eczema, nummular eczema, contact dermatitis, neurodermatitis, anogenital and senile pruritus, lichen planus, intertrigo and psoriasis.

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - methylprednisolone aceponate, quantity: 1 mg/g - ointment - excipient ingredients: white soft paraffin; microcrystalline wax; liquid paraffin; hydrogenated castor oil - tanilone fatty ointment is indicated for the topical treatment of eczema and psoriasis in adults and children.

Australia - English - Department of Health (Therapeutic Goods Administration)

organon pharma pty ltd - betamethasone dipropionate, quantity: 0.64 mg/g (equivalent: betamethasone, qty 0.5 mg/g) - ointment - excipient ingredients: white soft paraffin; liquid paraffin - indications as at 22 november 1995: diprosone is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. these include atopic eczema, infantile eczema, nummular eczema, contact dermatitis, neurodermatitis, anogenital and senile pruritus, lichen planus, intertrigo and psoriasis.

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharma pty ltd - mometasone furoate, quantity: 1 mg/g - ointment - excipient ingredients: white soft paraffin; hexylene glycol; white beeswax; purified water; propylene glycol monostearate; phosphoric acid - indicated for short-term (up to four continuous weeks) relief of inflammatory & pruritic manifestations of corticosteroid-responsive dermatoses, such as psoriasis & atopic dermatitis.

Australia - English - Department of Health (Therapeutic Goods Administration)

ego pharmaceuticals pty ltd - mometasone furoate, quantity: 1 mg/g - ointment - excipient ingredients: hexylene glycol; citric acid; light liquid paraffin; purified water; white soft paraffin; polyethylene; colloidal anhydrous silica; cetostearyl alcohol - for the short term (up to four continuous weeks) relief of inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses such as psoriasis and atopic dermatitis.

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - triamcinolone acetonide, quantity: 1 mg/g; nystatin, quantity: 100000 u/g; gramicidin, quantity: 0.25 mg/g; neomycin sulfate (equivalent: neomycin, qty 2.5 mg/g) - ointment - excipient ingredients: polyethylene; liquid paraffin - treatment of otitis externa (acute and chronic) when a topical corticosteroid is required and active infections with susceptible organisms are either present or likely to supervene. kenacomb otic is only recommended for short-term use.

Australia - English - Department of Health (Therapeutic Goods Administration)

leo pharma pty ltd - calcipotriol, quantity: 50 microgram/g; betamethasone dipropionate, quantity: 643 microgram/g (equivalent: betamethasone, qty 500 microgram/g) - ointment - excipient ingredients: liquid paraffin; polyoxypropylene-11 stearyl ether; dl-alpha-tocopherol; white soft paraffin; butylated hydroxytoluene - daivobet ointment is indicated for the once daily topical treatment of plaque-type psoriasis vulgaris amenable to topical therapy.

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - nystatin, quantity: 100000 u/g; triamcinolone acetonide, quantity: 1 mg/g; gramicidin, quantity: 0.25 mg/g; neomycin sulfate (equivalent: neomycin, qty 2.5 mg/g) - ointment - excipient ingredients: polyethylene; liquid paraffin - otocomb otic is indicated for the treatment of otitis externa (acute and chronic) when a topical corticosteroid is required and active infections with susceptible organisms are either present or likely to supervene.

Israel - English - Ministry of Health

organon pharma israel ltd., israel - betamethasone as dipropionate; salicylic acid - ointment - salicylic acid 30 mg/g; betamethasone as dipropionate 0.5 mg/g - betamethasone - betamethasone - provides anti inflammatory, antipruritic, anti allergic and chronic hyperkeratotic and dry keratolytic activity in the topical management of subacute dermatoses responsive to corticosteroid therapy.